A controlled clinical trial of Tranexamic Acid (TEA) was underaken to as sess its effectiveness in reducing early recurrence of haemorrhage in patients with aneurysmal subarchnoid haemorrhge (SAH). The series of control patients and patients having TEA which were consecutive. Of the 65 patients treated with TEA recurrence occurred in six (9%) and five patients died from recur rence of haemorrhage. Of the 64 patients in the control group, 17 (26%) pa tients had recurrent haemorrhage and eight patients died from it. Administra tion of tranexamic acid is found to have significantly reduced the early recur rence of haemorrhage.
Get full access to this article
View all access options for this article.
References
1.
McKissock W., Richardson A., Walsh L.: "Posterior Communicating" aneurysm. A controlled clinical trial of the conservative and surgical treatment of ruptured aneurysm. Lancet1:1203-6, 1960.
2.
Pakarinen S.: Incidence, aethiology and prognosis of primary subarchnoid haemorrhage. Acta Neurol Scand43: Suppl 29, 1967.
3.
Chowdhary UM, Carey PC, Hussein MM: Prevention of early recurrence of spontaneous subarchnoid haemorrhage. By Epsilon Aminocaproic Acid. Lancet1:741-743, 1979.
4.
Alvord EC, Loeser JD, Baily WL, et al: Subarchnoid haemorrhage due to ruptured aneurysms. A simple method of estimating prognosis. Arch Neurol27:273-84, 1972.
5.
Jane JA, Winn HR, Richardson AE: The natural history of intracranial aneurysms: Rebleeding rate during acute and long term period and implication for surgical management. Clin Neurosurg26:176-184, 1977.
6.
Gibbs JR, O'Gorman P.: Fibrinolysis in subarchnoid haemorrhage. Postgrad Med J43:779-84, 1967.
7.
Norlen G., Thulin CA: The use of antifibrinolytic substances in ruptured intracranial aneurysms . Neurochirurgia (Stuttg) 12:100-2, 1969.
8.
Gibbs JR, Corkill Agl: Use of an antifibrinolytic (Tranexamic Acid) in management of ruptured intracranial aneurysms. Postgrad Med J47:199-200, 1971.
9.
Tovi D.: The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarchnoid haemorrhage. Acta Neurol Scand49:163-75, 1973.
10.
Nibbelink DW : Antihypertensive and antifibrinolytic therapy following subarchnoid from ruptured intracranial aneurysms. Stroke5:432-3, 1974.
11.
Schisono G. : The use of antifibrinolytic in aneurysmal subarchnoid haemorrhage. Surg Neurol10:217-22, 1978.
12.
Chandra B.: Treatment of subarchnoid haemorrhage from ruptured intracranial aneurysms with Tranexamic Acid. Ann Neurol3:502-4, 1978.
13.
Maurice-Williams RS: Prolonged antifibrinolysis: An effective nonsurgical treatment for ruptured intracranial aneurysms. Br Med J1:945-7, 1978.
14.
Van Rossum J , Wintzen AR, Endtz LJ, et al: Effect of Tranexamic Acid on rebleeding after subarchnoid haemorrhage. A double blind controlled clinical trial. Ann Neurol2:242-5, 1977.
15.
Chowdhary UM , Sayed K.: Comparative clinical trial of EACA and TEA in prevention of early recurrence of subarchnoid haemorrhage. J Neurol Neurosurg Psychiat45:180-82, 1981.
16.
Lindsay KW, Vermulen M., Murray G., et al: Antifibrinolytic therapy in subarchnoid haemorrhage. Proceedings of Annual Meeting of American Association of Neurological Surgeons, 1984, pp. 9-10.
17.
Kasell NF, Rorner JC and Adams Jr HP: Antifibrinolytic therapy in the acute period following aneurysmal subarchnoid haemorrhage. J Neurosurg61:225-230, 1984.
18.
Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg28:14-19, 1968.
19.
Tovi D.: Studies of fibrinolysis in central nervous system with special reference to intracranial haemorrhage and to the effect of antifibrinolytic drugs. Umea University Medical Dissertation, No. 8, 1972.
20.
Tovi D., Thulin GA: Ability of Tranexamic Acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysms. Acta Neurol Scand48:257, 1972.
21.
Ameen AA, Illingworth R.: Antifibrinolytic treatment in the pre-operative management of subarchnoid haemorrhage caused by ruptured intracranial aneurysms. J Neurol Neurosurg Psychiat44:220-226, 1981.
22.
Chowdhary UM , Carey PC, Hussein MM: Total care of SAH patients: An optimistic approach. J Irish Med Assoc72:512-515, 1979.
Kassell NF, Sydney JP, Quentin JD, et al: Treatment of ischaemic deficits from vasospasm with intrasvascular volume expansion and induced anterial hypertension. Neurosurgery11:337-343, 1982.
25.
Allem GS, Hyo S.Ahn, Preziosi TJ, et al:Cerebral anterial spasm—a controlled trial of Nimodipine in patients with subarchnoid haemorrhage. N Engl J Med308:619-24, 1983.
26.
Peerless SJ : Pre- and postoperative management of cerebral aneurysms. Clin Neurosurg26:209-31, 1979.
27.
Sano K.: Cerebral vasospasm and aneurysm surgery. Clin Neurosurg30:13-56, 1983.
28.
Adams HP Jr, Kassell NJ, Torner JC, et al: Early management of aneurysmal subarchnoid haemorrhage. A report of co-operative aneurysm surgery. J Neurosurg54:141, 145, 1981.
29.
Kassell NG, Drake CG: Timing of aneurysm surgery. Neurosurg10:514-519, 1982.
